Published in J Biol Chem on October 25, 1979
Template recognition sequence for RNA primer synthesis by gene 4 protein of bacteriophage T7. Proc Natl Acad Sci U S A (1981) 1.97
Bacteriophage T3 and bacteriophage T7 virus-host cell interactions. Microbiol Rev (1981) 1.76
Alpha 1-antitrypsin Null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons. Am J Hum Genet (1990) 0.90
Spontaneous temperature-sensitive mutations in bacteriophage T7. J Virol (1985) 0.75
DNA replication: the rolling circle model. Cold Spring Harb Symp Quant Biol (1968) 8.37
Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol (1989) 5.69
Adenovirus-2 DNA contains an inverted terminal repetition. Proc Natl Acad Sci U S A (1972) 4.57
A potential noninvasive neurobiological test for Alzheimer's disease. Science (1994) 4.29
Molecular mechanisms in genetic recombination. Annu Rev Biochem (1982) 3.03
Initiation and reinitiation of DNA synthesis during replication of bacteriophage T7. Proc Natl Acad Sci U S A (1972) 2.95
Bacteriophage T7 DNA replication: a linear replicating intermediate (gradient centrifugation-electron microscopy-E. coli-DNA partial denaturation). Proc Natl Acad Sci U S A (1972) 2.87
On the mechanism of genetic recombination: electron microscopic observation of recombination intermediates. Proc Natl Acad Sci U S A (1976) 2.19
The amplification of ribosomal RNA genes involves a rolling circle intermediate. Proc Natl Acad Sci U S A (1973) 2.07
Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology (2003) 1.89
dnaG (primase)-dependent origins of DNA replication. Nucleotide sequences of the negative strand initiation sites of bacteriophages St-1, phi K, and alpha 3. J Biol Chem (1979) 1.82
Transfer factor. Ann Intern Med (1974) 1.65
Site-specific initiation of a DNA fragment: nucleotide sequence of the bacteriophage G4 negative-strand initiation site. Proc Natl Acad Sci U S A (1978) 1.57
Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther (1997) 1.55
The rolling circle for phiX DNA replication. II. Synthesis of single-stranded circles. Proc Natl Acad Sci U S A (1970) 1.48
In vitro system from Escherichia coli that catalyzes generalized genetic recombination. Proc Natl Acad Sci U S A (1978) 1.40
Regions of single-stranded DNA in the growing points of replicating bacteriophage T7 chromosomes. Proc Natl Acad Sci U S A (1972) 1.37
Effect of digital nerve stimuli on responses to electrical or magnetic stimulation of the human brain. J Physiol (1992) 1.35
On the mechanism of genetic recombination: the maturation of recombination intermediates. Proc Natl Acad Sci U S A (1977) 1.24
Analysis of the phiX DNA replication cycle by electron microscopy. Proc Natl Acad Sci U S A (1978) 1.19
Mycoplasma infection in the immunosuppressed leukemic patient. Arch Pathol Lab Med (1980) 1.19
The rolling circle for phi X DNA replication. 3. Synthesis of supercoiled duplex rings. Proc Natl Acad Sci U S A (1970) 1.17
The nucleolus and the rolling circle. Cold Spring Harb Symp Quant Biol (1974) 1.17
Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. Eur J Neurol (2006) 1.15
Biochemical assay designed to detect formation of recombination intermediates in vitro. Proc Natl Acad Sci U S A (1979) 1.11
The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups. Clin Pharmacol Ther (2001) 1.09
Complete secondary botulinum toxin therapy failure in blepharospasm. J Neurol (2000) 1.07
Transcranial electric and magnetic stimulation of the leg area of the human motor cortex: single motor unit and surface EMG responses in the tibialis anterior muscle. Electroencephalogr Clin Neurophysiol (1993) 1.07
Further observations on the facilitation of muscle responses to cortical stimulation by voluntary contraction. Electroencephalogr Clin Neurophysiol (1991) 1.04
A 'Southern Cross' method for the analysis of genome organization and the localization of transcription units. Gene (1986) 1.02
Transfer factor: a subcellular component that transmits information for specific immune responses. Proc Natl Acad Sci U S A (1974) 1.02
Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects. J Clin Pharmacol (2001) 1.02
Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line. Proc Natl Acad Sci U S A (1993) 1.01
On the chemical nature of transfer factor. Proc Natl Acad Sci U S A (1974) 0.98
Pharmacology of botulinum toxin: differences between type A preparations. Eur J Neurol (2006) 0.97
Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol (1999) 0.96
Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology (2005) 0.96
Cardiac screening by computerized auscultation. Am J Public Health Nations Health (1969) 0.94
Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology (2004) 0.94
Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose. J Clin Pharmacol (2001) 0.92
The rolling circle . capsid complex as an intermediate in phi X DNA replication and viral assembly. J Biol Chem (1980) 0.91
GPi-DBS may induce a hypokinetic gait disorder with freezing of gait in patients with dystonia. Neurology (2011) 0.91
Malrotation of the bowel in patients with congenital heart disease associated with splenic anomalies. Radiology (1971) 0.90
Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. Brain (2001) 0.90
Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm (Vienna) (2002) 0.89
Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method. Ther Drug Monit (2001) 0.89
Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration. Diabet Med (2010) 0.89
New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia. J Neurol Neurosurg Psychiatry (2007) 0.88
Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm. Am J Psychiatry (1998) 0.88
On muscle spindles, dystonia and botulinum toxin. Eur J Neurol (2010) 0.87
Demographic considerations in tacrolimus pharmacokinetics. Transplant Proc (1998) 0.87
Abnormal interaction between vestibular and voluntary head control in patients with spasmodic torticollis. Brain (2001) 0.87
Site-specific initiation of a DNA fragment. Proc Natl Acad Sci U S A (1978) 0.87
Botulinum toxin therapy of writer's cramp. Eur J Neurol (2006) 0.87
Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J Heart Lung Transplant (2001) 0.87
Single-stranded phage replication: positive- and negative-strand DNA synthesis. Cold Spring Harb Symp Quant Biol (1979) 0.86
Information processing in seven-month-old infants as a function of risk status. Child Dev (1988) 0.85
Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (1993) 0.84
Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia. Eur Arch Otorhinolaryngol (1997) 0.83
Tricho-rhino-phalangeal syndrome. Am J Dis Child (1969) 0.83
[Pathophysiological data and their consequences on diagnosis and therapy of degenerative joint diseases]. Med Monatsschr (1975) 0.83
The potential of BACE inhibitors for Alzheimer's therapy. Nat Biotechnol (2000) 0.83
Machado-Joseph disease presenting as severe generalised dystonia in a German patient. J Neurol (1999) 0.83
Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F. Neurotox Res (2006) 0.83
[Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model]. Aktuelle Urol (2009) 0.82
The recent excitement in the DNA growing point problem. Annu Rev Microbiol (1975) 0.82
DNA recombination: in vivo and in vitro studies. Cold Spring Harb Symp Quant Biol (1979) 0.82
Overactive bladder in Parkinson's disease: alteration of brainstem raphe detected by transcranial sonography. Eur J Neurol (2006) 0.81
Another case of focal segmental glomerulosclerosis in an acutely uraemic patient following interferon therapy. Nephrol Dial Transplant (1999) 0.81
Sonographic detection of basal ganglia abnormalities in spasmodic dysphonia. Eur J Neurol (2013) 0.81
Massive osteolysis in an infant. AJR Am J Roentgenol (1980) 0.81
Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design. J Clin Pharmacol (1999) 0.81
Symptoms, temperament, resiliency, and control in anxiety-disordered preschool children. J Am Acad Child Adolesc Psychiatry (1987) 0.80
Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia. J Neurol Neurosurg Psychiatry (2002) 0.80
Stapes fixation a proximal symphalangism. Z Kinderheilkd (1970) 0.80
DNA synaptase: an enzyme that fuses DNA molecules at a region of homology. Proc Natl Acad Sci U S A (1980) 0.80
Rapid rate transcranial magnetic stimulation--a safety study. Electroencephalogr Clin Neurophysiol (1997) 0.80
Transfer factor: warning on uncertainty of results. Ann Intern Med (1975) 0.79
Changes of transcranially evoked motor responses in man by midazolam, a short acting benzodiazepine. Neurosci Lett (1989) 0.78
Dyskinesias possibly induced by norpseudoephedrine. J Neurol (1994) 0.78
[Gout, pseudo-gout or hyperlipoproteinemia? (author's transl)]. Z Orthop Ihre Grenzgeb (1976) 0.78
Authors' statement: the existence and nature of "transfer factor/be/. Proc Natl Acad Sci U S A (1975) 0.78
Slow pre-movement cortical potentials do not reflect individual response to therapy in writer's cramp. Clin Neurophysiol (2009) 0.77
Practical methods of bonding direct and indirect. J Clin Orthod (1975) 0.77
Change in physical and psychosocial domains of quality of life from before to after discharge post left ventricular assist device implantation. J Heart Lung Transplant (2001) 0.77
99mTc-hexamethylpropylene amine oxime SPECT and X-ray CT in acute cerebral ischaemia. J Neurol (1990) 0.77
Bioequivalence of a new strength tacrolimus capsule under development. Transplant Proc (1998) 0.76
Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjects. J Clin Pharmacol (2001) 0.76
Clozapine treatment of spasmodic torticollis. Neurology (1994) 0.76
The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease. Ann N Y Acad Sci (1992) 0.76
Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg. Clin Ther (1999) 0.76
[Dystonia as the cause of pharyngolaryngeal motility disorders]. HNO (1995) 0.75
[Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement]. Nervenarzt (2008) 0.75